FDA/The Osteosarcoma Institute (OSI) Workshop: Advancing Osteosarcoma Drug Development – Connecting Research and Regulatory Pathways for Improved Outcomes
The FDA OCE and The OSI are hosting a workshop focused on addressing key challenges in osteosarcoma drug development.